Related Experiment Videos
[Consensus heart failure. Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing]
P A de Graeff1, A H Balk, W J Remme
1Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing, Utrecht.
Insights
Guidelines for heart failure diagnosis and treatment were established in 1994 due to evolving practices. The consensus focused on addressing controversies and improving patient outcomes through tailored pharmacotherapy, including ACE inhibitors.
Area of Science:
- Cardiology
- Internal Medicine
- Gerontology
Background:
- Heart failure presents a significant public health challenge, characterized by cardiac dysfunction and associated symptoms.
- Existing controversies in diagnosis and treatment necessitated updated guidelines.
Framework:
- Guidelines established for diagnosis and treatment of heart failure.
- Focus on identifying and addressing underlying causes and contributing factors.
- Diagnostic procedures should be tailored based on diagnostic certainty and therapeutic implications.
Implementation:
- Treatment strategies incorporate non-medical measures.
- Pharmacotherapy selection prioritizes symptom relief, morbidity, and mortality reduction.
- Angiotensin-converting enzyme (ACE) inhibitors are central to the pharmacotherapeutic approach.
Implications:
- Specific attention is required for high-risk groups, including patients with arrhythmias and the elderly.
- Emphasis on the prevention of heart failure is crucial.
- Updated guidelines aim to resolve diagnostic and therapeutic controversies among healthcare professionals.
Abstract:
Consensus heart failure--On June 17th, 1994, a consensus meeting was organised to establish guidelines for the diagnosis and treatment of heart failure. Reason to do this were controversies, especially among general practitioners, cardiologists, internists and gerontologists, which arise as a consequence of new diagnostic modalities (such as echocardiography) and altered aims of the treatment (besides relief of symptoms reduction of morbidity and mortality). A number of starting points were formulated by a preparatory committee: Heart failure constitutes a major health problem. It is defined by cardiac dysfunction with accompanying symptoms. Diagnosis and treatment should focus first on causes or contributing factors. The extent of diagnostic procedures depends on possible doubts with regard to diagnosis and aetiology and therapeutic consequences. Treatment should include non-medical measures. Apart from relief of symptoms, the choice of drugs is also determined by their potential to reduce morbidity and mortality. The pharmacotherapeutic approach has to be tailored to the needs of the patient with a central role for the ACE inhibitors. Patients with concomitant arrhythmias and (very) old patients form separate risk groups. Further attention should be paid to the prevention of heart failure.